Oncolytics Biotech® Inc. Announces Opening Of Enrollment In U.S. Phase I Colorectal Cancer Study

Links shared publicly online about this topic.

  • 588
    total visits

Oncolytics Biotech® Inc. Announces Opening Of Enrollment In U.S. Phase I Colorectal Cancer Study

medicalnewstoday.com

Oncolytics Biotech Inc. (Oncolytics) (TSX:ONC, NASDAQ: ONCY) announced that a U.S. Phase I study of REOLYSIN® in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + I

View full resource at medicalnewstoday.com

Tags: Cancer, Rectal Cancer, Colon Cancer, Colorectal Cancer Medication, Biotech, Wellcovorin, 5-FU

  • Share

Most Recently Shared on January 11, 2011 at 9:05 pm By:

mnt_clinical MNT Clinical Trials

Oncolytics Biotech® Inc. Announces Opening Of Enrollment In U.S. Phase I Colorectal Cancer Study http://mnt.to/3PR9 #clinicaltrials

1 year ago...

Also Shared By:

MNT Colorectal Canc MNT Colorectal Canc

MNT Pharma News MNT Pharma News

FDA favors first drug for HIV prevention

pharma411.visibli.com — “FDA favors first drug for HIV preventionView full resource at pharma411.visibli.com

  • View Related
  • Share

Most Recently Shared on May 8, 2012 at 4:43 pm By:

Ex-Sanofi chemist locked up after theft - FierceBiotech

fiercebiotech.com — “After being accused of bilking her former employer, a court sentenced ex-Sanofi chemist Yuan Li to serve a year and half in prison and pay $131,000 in restitution, Pharmalot reported, citing court documents.View full resource at fiercebiotech.com

  • View Related
  • Share

Most Recently Shared on May 8, 2012 at 4:17 pm By:

FierceBiotech FierceBiotech Health News

Ex-Sanofi chemist locked up after theft http://t.co/mjqsh2Jk $SNY

3 weeks ago...

Drug-making plant blooms : Nature News & Comment

nature.com — “Approval of a ‘biologic’ manufactured in plant cells may pave the way for similar products.View full resource at nature.com

  • View Related
  • Share

Most Recently Shared on May 8, 2012 at 3:52 pm By:

New technique could identify drugs that help fight broad range of viruses

labspaces.net — “Results of a new study demonstrate the feasibility of a novel strategy in drug discovery: screening large numbers of existing drugs — often already approved for other uses — to see which ones activate genes that boost natural immunity.View full resource at labspaces.net

  • View Related
  • Share

Most Recently Shared on May 7, 2012 at 3:45 pm By:

LabSpaces Brian Krueger Health News

New technique could identify drugs that help fight broad range of viruses - http://t.co/XLIadNIg

4 weeks ago...

Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill? | Xconomy

xconomy.com — “A recent meeting focused on “Reinventing Biotech’s Business Model” provided an interesting window into the spectrum of approaches being used to create newView full resource at xconomy.com

  • View Related
  • Share

Most Recently Shared on May 3, 2012 at 8:38 pm By:

ldtimmerman Luke Timmerman Health Communicator

Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill? Stewart Lyman guest post http://t.co/TvEXpc4u

4 weeks ago...

Researchers develop 'smart' nanostructures for drug delivery - FierceDrugDelivery

fiercedrugdelivery.com — “Researchers develop 'smart' nanostructures for drug delivery - FierceDrugDeliveryView full resource at fiercedrugdelivery.com

  • View Related
  • Share

Most Recently Shared on May 2, 2012 at 12:38 pm By:

FierceBiotech FierceBiotech Health News

Researchers develop 'smart' nanostructures for drug delivery http://t.co/ev65CgPo #biotech via @DamianFierce

4 weeks ago...

Swedish discovery could be key to better transdermal delivery - FierceDrugDelivery

fiercedrugdelivery.com — “Swedish discovery could be key to better transdermal delivery - FierceDrugDeliveryView full resource at fiercedrugdelivery.com

  • View Related
  • Share

Most Recently Shared on May 2, 2012 at 12:28 pm By:

FierceBiotech FierceBiotech Health News

Swedish discovery could be key to better transdermal delivery http://t.co/hKOW5a3q #biotech $ECTE

4 weeks ago...

Savient hammered after hedge fund claims it's bankrupt - FierceBiotech

fiercebiotech.com — “Savient hammered after hedge fund claims it's bankrupt - FierceBiotechView full resource at fiercebiotech.com

  • View Related
  • Share

Most Recently Shared on May 2, 2012 at 12:23 pm By:

California Heads for Vote on Modified Food Labeling - Bloomberg

bloomberg.com — “Californians are on course to vote whether genetically modified food must be labeled following a campaign that has targeted Monsanto Co. and other biotech-crop companies.View full resource at bloomberg.com

  • View Related
  • Share

Most Recently Shared on May 2, 2012 at 5:29 am By:

Darlene Gant, Mom Dying Of Cancer, Inspires Drug Maker To Release Trial Drug Pertuzumab Via YouTube Video

huffingtonpost.com — “When doctors told Tampa Bay, Fla., woman Darlene Gant earlier this year that her breast cancer had returned, they also gave her some good news: The biotech firm Genentech had developed a potentially lifesaving drug called Pertuzumab that was expected to be approved by the FDA in June. But Gant, 46, knew that she might not live that long, so she and her husband decided to record a video pleading for the FDA to approve her use of the drug under the compassionate use clause, which states that patieView full resource at huffingtonpost.com

  • View Related
  • Share

Most Recently Shared on May 2, 2012 at 2:56 am By:

DrCarolynAImpowerage. Mom to a 1.5 year old who enjoys staying active." /> Dr. Carolyn Anderson Doctor, Surgeon, Ophthalmologist, Physician, and Active Health Library

Dying mom's video convinces drug company to release a drug early to help her. http://t.co/TfBm7bkZ Interesting implications for others

4 weeks ago...

U.S. FDA approves Pfizer/Protalix drug for Gaucher | Reuters

in.reuters.com — “WASHINGTON (Reuters) - U.S. drug regulators gave the nod on Tuesday to Protalix Biotherapeutics Inc and Pfizer Inc's experimental biotech drug for a form of the rare genetic disease Gaucher.The Food andView full resource at in.reuters.com

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 9:38 pm By:

Reuters_Health Reuters Health Health News

FDA approves Pfizer/Protalix drug for Gaucher http://t.co/PG7ko4ec

1 month ago...

Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs | Xconomy

xconomy.com — “Cambridge, MA-based Mersana Therapeutics is working in one of the hottest areas of biotech research---it’s figuring out new ways to attach potent anti-cancerView full resource at xconomy.com

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 5:42 pm By:

ldtimmerman Luke Timmerman Health Communicator

Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs | Xconomy http://t.co/eEuLtOIc

1 month ago...

Abbott tries to throw up roadblock to Humira biosim - FierceBiotech

fiercebiotech.com — “Abbott tries to throw up roadblock to Humira biosim - FierceBiotechView full resource at fiercebiotech.com

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 4:37 pm By:

Pfizer turns to late-stage pipeline to make up for Lipitor crash - FierceBiotech

fiercebiotech.com — “Pfizer turns to late-stage pipeline to make up for Lipitor crash - FierceBiotechView full resource at fiercebiotech.com

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 3:47 pm By:

FierceBiotech FierceBiotech Health News

Pfizer turns to late-stage pipeline to make up for #Lipitor crash http://t.co/2SCeBslk $PFE @Pfizer_news #pharma

1 month ago...

The First Drug With A $1 Million Price Tag May Already Be On The Market - Forbes

forbes.com — “The medicine doesn't cost $1 million now, but it may if the children it is helping grow up. Are we thinking deeply enough about the implications of high cost drugs?View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 3:27 pm By:

matthewherper Matthew Herper

The First Drug With A $1 Million Price Tag My Already Be On The Market - Forbes http://t.co/9e0bmXMj

1 month ago...

Advertisement